-DOCSTART- -X- O
Antisense -X- _ B-Intervention
antimicrobial -X- _ I-Intervention
therapeutics -X- _ I-Intervention
are -X- _ O
synthetic -X- _ O
oligomers -X- _ O
that -X- _ O
silence -X- _ O
expression -X- _ O
of -X- _ O
specific -X- _ O
genes. -X- _ O
This -X- _ O
specificity -X- _ O
confers -X- _ O
an -X- _ O
advantage -X- _ O
over -X- _ O
broad-spectrum -X- _ O
antibiotics -X- _ O
by -X- _ O
avoiding -X- _ O
unintended -X- _ O
effects -X- _ O
on -X- _ O
commensal -X- _ O
bacteria. -X- _ O
The -X- _ O
sequence-specificity -X- _ O
and -X- _ O
short -X- _ O
length -X- _ O
of -X- _ O
antisense -X- _ O
antimicrobials -X- _ O
also -X- _ O
pose -X- _ O
little -X- _ O
risk -X- _ O
to -X- _ O
human -X- _ O
gene -X- _ O
expression. -X- _ O
Because -X- _ O
antisense -X- _ B-Intervention
antimicrobials -X- _ I-Intervention
are -X- _ O
a -X- _ O
platform -X- _ O
technology -X- _ O
, -X- _ O
they -X- _ O
can -X- _ O
be -X- _ O
rapidly -X- _ O
designed -X- _ O
and -X- _ O
synthesized -X- _ O
to -X- _ O
target -X- _ O
almost -X- _ O
any -X- _ O
microbe. -X- _ O
This -X- _ O
reduces -X- _ O
drug -X- _ B-Outcome
discovery -X- _ I-Outcome
time -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
provides -X- _ I-Outcome
flexibility -X- _ I-Outcome
and -X- _ I-Outcome
a -X- _ I-Outcome
rational -X- _ I-Outcome
approach -X- _ I-Outcome
to -X- _ I-Outcome
drug -X- _ I-Outcome
development. -X- _ I-Outcome
Recent -X- _ O
work -X- _ O
has -X- _ O
shown -X- _ O
that -X- _ O
antisense -X- _ O
technology -X- _ O
has -X- _ O
the -X- _ O
potential -X- _ O
to -X- _ O
address -X- _ B-Outcome
the -X- _ I-Outcome
antibiotic-resistance -X- _ I-Outcome
crisis -X- _ I-Outcome
, -X- _ I-Outcome
since -X- _ I-Outcome
resistance -X- _ I-Outcome
mechanisms -X- _ I-Outcome
for -X- _ I-Outcome
standard -X- _ I-Outcome
antibiotics -X- _ I-Outcome
apparently -X- _ I-Outcome
have -X- _ I-Outcome
no -X- _ I-Outcome
effect -X- _ I-Outcome
on -X- _ I-Outcome
antisense -X- _ I-Outcome
antimicrobials. -X- _ I-Outcome
Here -X- _ O
, -X- _ O
we -X- _ O
describe -X- _ O
current -X- _ O
reports -X- _ O
of -X- _ O
antisense -X- _ O
antimicrobials -X- _ O
targeted -X- _ O
against -X- _ O
viruses -X- _ O
, -X- _ O
parasites -X- _ O
, -X- _ O
and -X- _ O
bacteria -X- _ O
. -X- _ O

